BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. (BCTXW) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BCTXW · as of Jun 8, 2026
Key Statistics
Explore BriaCell Therapeutics Corp. Data
bctxw stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bctxw competitorsBCTXW
CELU
KTTA
LIXT
NUWE
OCEAStock Performance
Full HistoryAbout BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, currently in Phase 3, dedicated to revolutionizing cancer treatment through its innovative cellular immunotherapies. Its flagship…
what is briacell therapeutics corp. · bctxw stock overview · briacell therapeutics corp. company profile · who is briacell therapeutics corp. ceo · bctxw NASDAQ · briacell therapeutics corp. headquarters · briacell therapeutics corp. business segments
About Stock Overview & Key Data
BriaCell Therapeutics Corp. (BCTXW) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 13, 2012. As of the latest trading session, BCTXW stock price is $0.00, with a market capitalization of $1,695. The stock has returned -99.00% over the past 12 months and -98.44% year-to-date.
In fiscal year 2025, BriaCell Therapeutics Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BriaCell Therapeutics Corp. (BCTXW) stock price is $0.00. The stock is traded on NASDAQ under the ticker symbol BCTXW. The 52-week range is $0.00 – $0.06.